Novel and bone targeted agents for CRPC

Date 29 September 2012
Event ESMO Congress 2012
Session The current management of castrate-resistant prostate cancer (CRPC) - Repetition
Topics Anticancer agents
Prostate Cancer
Biological therapy
Presenter Karim Fizazi
Authors K. Fizazi
  • Department Of Cancer Medicine, Institut Gustave Roussy, University of Paris, 94805 - Villejuif CEDEX/FR